The Efficacy of Silymarin in Decreasing Transaminase Activities in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial

Authors
Category Primary study
JournalHepatitis Monthly
Year 2008
This article has no abstract
Epistemonikos ID: de3ad45e453b46f383543eb7bcb32790aacc60cf
First added on: Apr 28, 2026